Skip to content
10-Q

Quarterly Report

ACCELERON PHARMA INC.

0001280600-21-000078

← back to feed
Filed
Nov 4, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 1, 2021 61.16M sh
Shares Diluted Q3 2021 · Sep 30, 2021 60.94M sh
Shares Diluted Q3 2021 · Sep 30, 2021 60.75M sh
Shares Diluted Q3 2021 · Sep 30, 2020 59.64M sh
Shares Diluted Q3 2021 · Sep 30, 2020 55.64M sh
Capex Q3 2021 · Sep 30, 2021 $4.3M
Capex Q3 2021 · Sep 30, 2020 $3.3M
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$223.23M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$92.2M
Short Term Investments Q3 2021 · Sep 30, 2021 $254.11M
Short Term Investments Q3 2021 · Dec 31, 2020 $178.95M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $336.46M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $670.95M
Cash And Equivalents Q3 2021 · Sep 30, 2020 $729.69M
Stockholders Equity Q3 2021 · Sep 30, 2021 $718.15M
Stockholders Equity Q3 2021 · Jun 30, 2021 $763.03M
Stockholders Equity Q3 2021 · Mar 31, 2021 $810.83M
Stockholders Equity Q3 2021 · Dec 31, 2020 $855.11M
Stockholders Equity Q3 2021 · Sep 30, 2020 $895.14M
Stockholders Equity Q3 2021 · Jun 30, 2020 $421.62M
Stockholders Equity Q3 2021 · Mar 31, 2020 $413.82M
Stockholders Equity Q3 2021 · Dec 31, 2019 $449.48M
Current Liabilities Q3 2021 · Sep 30, 2021 $57.37M
Current Liabilities Q3 2021 · Dec 31, 2020 $60.16M
Total Liabilities Q3 2021 · Sep 30, 2021 $69.7M
Total Liabilities Q3 2021 · Dec 31, 2020 $77.23M
Current Assets Q3 2021 · Sep 30, 2021 $696.61M
Current Assets Q3 2021 · Dec 31, 2020 $893.27M
Total Assets Q3 2021 · Sep 30, 2021 $787.85M
Total Assets Q3 2021 · Dec 31, 2020 $932.34M
Eps Diluted Q3 2021 · Sep 30, 2021 −$1.16
Eps Diluted Q3 2021 · Sep 30, 2021 −$3.25
Eps Diluted Q3 2021 · Sep 30, 2020 −$0.66
Eps Diluted Q3 2021 · Sep 30, 2020 −$1.95
Eps Basic Q3 2021 · Sep 30, 2021 −$1.16
Eps Basic Q3 2021 · Sep 30, 2021 −$3.25
Eps Basic Q3 2021 · Sep 30, 2020 −$0.66
Eps Basic Q3 2021 · Sep 30, 2020 −$1.95
Sga Expense Q3 2021 · Sep 30, 2021 $45.11M
Sga Expense Q3 2021 · Sep 30, 2021 $111.65M
Sga Expense Q3 2021 · Sep 30, 2020 $21.04M
Sga Expense Q3 2021 · Sep 30, 2020 $59.71M
Rd Expense Q3 2021 · Sep 30, 2021 $59.72M
Rd Expense Q3 2021 · Sep 30, 2021 $173.15M
Rd Expense Q3 2021 · Sep 30, 2020 $40.75M
Rd Expense Q3 2021 · Sep 30, 2020 $116.66M
Net Income Q3 2021 · Sep 30, 2021 −$70.47M
Net Income Q3 2021 · Sep 30, 2021 −$197.46M
Net Income Q3 2021 · Jun 30, 2021 −$63.52M
Net Income Q3 2021 · Mar 31, 2021 −$63.47M
Net Income Q3 2021 · Sep 30, 2020 −$39.25M
Net Income Q3 2021 · Sep 30, 2020 −$108.64M
Net Income Q3 2021 · Jun 30, 2020 −$18.45M
Net Income Q3 2021 · Mar 31, 2020 −$50.94M
Operating Income Q3 2021 · Sep 30, 2021 −$70.63M
Operating Income Q3 2021 · Sep 30, 2021 −$197.9M
Operating Income Q3 2021 · Sep 30, 2020 −$39.23M
Operating Income Q3 2021 · Sep 30, 2020 −$109.71M
Revenue Q3 2021 · Sep 30, 2021 $34.2M
Revenue Q3 2021 · Sep 30, 2021 $86.9M
Revenue Q3 2021 · Sep 30, 2020 $22.56M
Revenue Q3 2021 · Sep 30, 2020 $66.66M